Oxybutynin and Soliris drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Oxybutynin and Soliris. Common interactions include pain among females and abdominal abscess among males.

The phase IV clinical study analyzes what interactions people who take Oxybutynin and Soliris have. It is created by eHealthMe based on reports of 14 people who take Oxybutynin and Soliris from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Jan, 30, 2023

14 people who take Oxybutynin and Soliris together, and have interactions are studied.

What is Oxybutynin?

Oxybutynin has active ingredients of oxybutynin. It is often used in urge incontinence. eHealthMe is studying from 19,743 Oxybutynin users for its effectiveness, alternative drugs and more.

What is Soliris?

Soliris has active ingredients of eculizumab. It is often used in paroxysmal nocturnal hemoglobinuria (pnh). eHealthMe is studying from 53,866 Soliris users for its effectiveness, alternative drugs and more.

Number of Oxybutynin and Soliris reports submitted per year:

Common Oxybutynin and Soliris drug interactions by gender *:

female:

Pain
Amnesia
Arthropathy
Asthenia
Bronchitis
Dizziness
Dyspnoea
Fall
Fatigue
Gastrointestinal disorder

male:

Abdominal abscess
Adrenal insufficiency
Hypokalaemia
Hypotension
Joint dislocation
Oedema peripheral
Pseudomonas infection
Psychotic disorder
Pulmonary embolism
Renal tubular necrosis

Common Oxybutynin and Soliris drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Abdominal abscess
Adrenal insufficiency
Cardiac tamponade
Delusion
Depression
Enterococcal infection
Escherichia infection
Fall
Fungal infection
Genital disorder male

30-39:

Blindness
Burning sensation
Neuralgia
Pain
Rash
Skin reaction

40-49:

Ascites
Hepatic cirrhosis
Hepatic failure
Priapism
Pruritus
Rash

50-59:

Amnesia
Arthropathy
Headache
Hernia
Hypotension
Insomnia
Intervertebral disc protrusion
Loss of consciousness
Memory impairment
Migraine

60+:

n/a

Common conditions people have *:

Haemolytic Uraemic Syndrome (blood clotting disease caused by e. coli infection, birth control pills, pneumonia, medications, and more): 7 people, 50.00%
Itching: 4 people, 28.57%
Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 2 people, 14.29%
Blood Creatinine Increased: 2 people, 14.29%
High Blood Pressure: 2 people, 14.29%
Urticaria (rash of round, red welts on the skin that itch intensely): 1 person, 7.14%
Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 1 person, 7.14%
Bedwetting: 1 person, 7.14%
Cough: 1 person, 7.14%
Diarrhea: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Oxybutynin and Soliris?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.